At the time, I wondered whether Welch and the Times would face sanctions. Now we have the answer.
JAMA’s editor-in-chief, Howard Bauchner, tells Embargo Watch: Read the rest of this entry »
Trouble is, the op-ed broke the embargo on the JAMA Internal Medicine paper.
From the JAMA press office today: Read the rest of this entry »
Due to circumstances beyond our control we are lifting embargoes on all European Cancer Congress press releases as of now. The abstracts are all online now, including late-breaking abstracts. They can be found here:
Therefore, for the remainder of the Congress we will email out the rest of our press releases either on the day of presentation to the congress or the press conference (whichever is earlier) and they will be for immediate release.
What happened? ECCO tells Embargo Watch: Read the rest of this entry »
Earlier this week, Brigham & Women’s Hospital sent out a press released titled, “The truth isn’t sweet when it comes to artificial sweeteners.” It’s the kind of release that was likely to grab lots of reporters’ attention.
But today, the hospital did something familiar during political season: They walked back that press release, apologizing for having sent it out.
Confusion as JNCI yanks press release on embargoed breast density-cancer study after authors see error
Please disregard this MTM, which was sent out on Friday June 29, 2012. The data in the study changed so we are no longer putting out a press release for the study.
The original release was headlined:
Percent Density May Be As Strong a Risk Factor as Variation in Breast Density for Breast Cancer
MTM stands for “memo to the media.” What wasn’t clear was whether the new notice meant the release was being pulled back, or the study itself, but the JNCI press office said it was just the release.
But the Mayo Clinic’s Celine Vachon told Embargo Watch: Read the rest of this entry »
In what has become an annual ritual, the American Society of Clinical Oncology (ASCO) meeting now underway in Chicago has been the subject of an embargo break. From a message sent by ASCO last night to reporters: Read the rest of this entry »
The U.S. Preventive Services Task Force (USPSTF) will publish its final recommendations on screening for cervical cancer in the Annals of Internal Medicine and on their website on Wednesday, March 14th.
This announcement is currently public information.
The announcement then details how reporters can obtain embargoed copies of a USPSTF press release on the new guidelines, and the recommendations themselves.
I won’t be breaking the embargo by saying that this involves — wait for it — women. And the USPSTF published a draft version of the guidelines for public comment in October.
That move, however Read the rest of this entry »
The American Association for Cancer Research (AACR) lifted the embargo early yesterday on a study of diet and breast cancer after MSNBC ran a story ahead of schedule. From the AACR press office:
The embargo on the Dr. Michelle Harvie study, “Intermittent, Low-Carbohydrate Diets More Successful Than Standard Dieting, Present Possible Intervention for Breast Cancer Prevention,” originally scheduled for 5 p.m. CT today has been lifted due to an embargo break by MSNBC this morning. All reporters are free to release their stories at this time.
Dr. Harvie is scheduled to present this study in a poster presentation at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium today at 5 p.m. CT.
I contacted the AACR to ask whether MSNBC would face any sanctions, but haven’t heard back.
Elsevier obstetrics-gynecology journal “stunned” to learn embargoed cervical cancer screening study is already online
One of the services we offer readers at my day job as executive editor of Reuters Health is links, whenever available, to our primary sources. We were doing it before Ben Goldacre asked why journalists don’t link to studies, but if you want to know why we do, read his column.
Many of the studies we cover are never embargoed. (Imagine that: I run a health news service that doesn’t rely solely on embargoed material.) So as per our practice, when a member of our staff was working on a story about excess cervical cancer screening from the American Journal of Obstetrics and Gynecology (AJOG) embargoed for a minute after midnight this morning, she tried to find a digital object identifier (DOI) she could include in the piece. Turns out it was right in the press release:
The article is “Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States” by Katherine B. Roland, MPH; Ashwini Soman, MBBS, MPH; Vicki B. Benard, PhD; Mona Saraiya, MD, MPH (doi: 10.1016/j.ajog.2011.06.001). It will appear in the American Journal of Obstetrics & Gynecology, Volume 205, Issue 5 (November 2011) published by Elsevier.
She went to the DOI, to see if it said it would be live at a later date, or gave us an error, so we could decide what to put in the story. Then she had a surprise. Read the rest of this entry »
Due to an embargo break by Bloomberg News, the embargo on the paper “New Inhibitor Prevented Lesions, Reduced Tumor Size in Basal Cell Cancer,” (view the abstract) which had been previously set at 10:00 a.m. on Saturday April 2, 2011, is released. Reporters and editors planning to do the story can release their items at this time.